+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030- Product Image
Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140287
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical contract research and manufacturing services are experiencing profound change driven by advanced therapies, complex regulatory environments, and a marked shift toward integrated solutions. Senior decision-makers face new challenges and opportunities as they navigate evolving frameworks, global trade variables, and technological disruption across the pharmaceutical R&D and production ecosystem.

Market Snapshot: Customized Pharmaceutical R&D and Production Services

Over the past decade, this market has transformed through scientific breakthroughs, digitalization, and the transition toward precision medicine. Growth has accelerated due to robust investment in biologics, advanced therapies, and the demand for integrated approaches combining R&D, regulatory affairs, and manufacturing. Expanding biologic pipelines and the increased importance of multidisciplinary drug development have produced new dynamics within contract manufacturing organizations and research partners. Companies now prioritize seamless project management, cross-functional expertise, and flexible manufacturing to deliver consistent, compliant outcomes across diverse geographies and therapeutic application areas, ensuring agility in a competitive industry.

Scope & Segmentation of the Pharmaceutical Contract Research and Manufacturing Market

  • Service Category: Integrated development, regulatory affairs, toxicology, API manufacturing, fill-finish, formulation manufacturing, clinical development, drug discovery, and preclinical development.
  • Molecule Category: Biologics (including monoclonal antibodies, recombinant proteins, vaccines), gene therapies (nonviral and viral vectors), peptides and oligonucleotides (oligonucleotide therapeutics, synthetic peptides), and small molecules.
  • Customer Category: Academic institutions, biotechnology companies (established and start-ups), contract research organizations, and pharmaceutical companies (generic, large, mid-sized).
  • Therapeutic Area: Cardiovascular (hypertension, stroke), central nervous system (Alzheimer disease, Parkinson disease), infectious diseases (bacterial, viral), and oncology (hematological malignancies, solid tumors).
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe / Middle East / Africa (including United Kingdom, Germany, France, Russia, United Arab Emirates, Saudi Arabia, South Africa), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Key Technologies: Artificial intelligence and machine learning, flexible and modular manufacturing, single-use bioreactors, continuous processing, and advanced analytics.

Key Takeaways for Senior Decision-Makers

  • Integrated project models align regulatory, clinical, and manufacturing functions for smoother transitions from research to commercialization.
  • Adoption of digital tools and predictive analytics is reshaping clinical trial simulation, lead optimization, and supply chain planning.
  • Localized manufacturing enables streamlined IP protection, strengthens quality oversight, and reduces exposure to shifting trade policies.
  • Partnership breadth across emerging therapeutic areas, such as gene and cell therapies, is increasingly critical for sustained differentiation.
  • Global service providers balance operational flexibility and risk mitigation by optimizing their facility network and regional presence.
  • Customizable, end-to-end solutions are vital for meeting the evolving compliance requirements of multidisciplinary drug pipelines.

Tariff Impact: U.S. Policy Changes and Global Pharmaceutical Supply Chains

In 2025, new United States tariff measures introduced additional complexity across pharmaceutical supply chains. End-to-end service providers are adjusting sourcing by identifying suppliers outside tariff-affected zones to ensure raw material reliability and compliance. Several contract manufacturers are expanding U.S.-based operations to mitigate import levies and reduce project delays, with benefits including tighter control of intellectual property and improved regulatory collaboration. Navigating these changes requires agile project planning and embedding tariff analysis early in decision-making processes to maintain continuity and optimize cost-to-market timelines for drug sponsors.

Methodology & Data Sources

This assessment synthesizes primary interviews with industry executives, scientific experts, and regulatory leaders across major geographies. Insights were further validated through regulatory filings, peer-reviewed literature, secondary research on technology trends, and cross-referencing of industry consortium reports to ensure context and relevance.

Why This Report Matters

  • Delivers actionable insights to enhance portfolio planning and guide investment in integrated contract research and manufacturing partnerships.
  • Equips senior managers with region-specific trends and risk analysis to drive resilient, compliant, and innovative R&D strategies.
  • Facilitates competitive benchmarking through analysis of the latest service models, technology trends, and emerging therapeutic opportunities.

Conclusion

By leveraging data-driven frameworks, digital platforms, and proactive risk management, organizations can lead next-generation pharmaceutical innovation. Strategic partnerships across R&D and manufacturing are key to achieving operational excellence and ensuring market leadership in customized therapies.

Market Segmentation & Coverage

  • Service Category: Integrated development, DM-PK, regulatory affairs, toxicology, API, fill-finish, formulation manufacturing, clinical, drug discovery, preclinical.
  • Molecule Category: Biologics, gene therapy, peptides, oligonucleotides, small molecules.
  • Customer Category: Academic, biotech (established, start-ups), CROs, pharma (generic, mid-sized, large).
  • Therapeutic Area: Cardiovascular, CNS, infectious, oncology.
  • Region: Americas (US, Canada, Mexico, Brazil, Argentina), EMEA (UK, Germany, France, Russia, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Company Profiles: Lonza Group AG, Catalent Inc., Thermo Fisher Scientific Inc., WuXi AppTec Co., Ltd., Samsung Biologics Co., Ltd., Boehringer Ingelheim International GmbH, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Recipharm AB, AGC Biologics Inc., Rentschler Biopharma SE.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven molecular design platforms into custom drug development pipelines for expedited lead optimization
5.2. Expansion of capacity in modular continuous manufacturing facilities to support rapid scale-up of personalized biologics production
5.3. Adoption of digital twin and IoT-enabled quality control systems to ensure compliance in outsourced pharmaceutical manufacturing
5.4. Growing demand for cell and gene therapy contract development and manufacturing organizations offering specialized viral vector production and purification services
5.5. Strategic partnerships between CDMOs and biotech startups to co-develop novel small-molecule therapies under risk-sharing models
5.6. Implementation of green chemistry practices and sustainable bioprocessing solutions in custom pharmaceutical manufacturing operations
5.7. Leveraging high-throughput screening and microfluidic process intensification for accelerated API development and formulation
5.8. Regulatory harmonization and accelerated approval pathways shaping outsourced services for first-in-human oncology trials
5.9. Integration of decentralized regional manufacturing sites to minimize supply chain disruptions and ensure rapid product delivery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Customized R&D & Production Services Market, by Service Category
8.1. Introduction
8.2. Integrated Development Services
8.2.1. Dmpk
8.2.2. Regulatory Affairs
8.2.3. Toxicology
8.3. Manufacturing Services
8.3.1. Api Manufacturing
8.3.2. Fill Finish Manufacturing
8.3.3. Formulation Manufacturing
8.4. Research And Development Services
8.4.1. Clinical Development
8.4.2. Drug Discovery
8.4.3. Preclinical Development
9. Pharmaceutical Customized R&D & Production Services Market, by Molecule Category
9.1. Introduction
9.2. Biologics
9.2.1. Monoclonal Antibody
9.2.2. Recombinant Protein
9.2.3. Vaccines
9.3. Gene Therapy
9.3.1. Nonviral Vector
9.3.2. Viral Vector
9.4. Peptides And Oligonucleotides
9.4.1. Oligonucleotide Therapeutics
9.4.2. Synthetic Peptide
9.5. Small Molecule
10. Pharmaceutical Customized R&D & Production Services Market, by Customer Category
10.1. Introduction
10.2. Academic Institutions
10.3. Biotechnology Companies
10.3.1. Established Biotech
10.3.2. Startups
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
10.5.1. Generic Pharma
10.5.2. Large Pharma
10.5.3. Mid Sized Pharma
11. Pharmaceutical Customized R&D & Production Services Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.2.1. Hypertension
11.2.2. Stroke
11.3. Central Nervous System
11.3.1. Alzheimer Disease
11.3.2. Parkinson Disease
11.4. Infectious Disease
11.4.1. Bacterial Infection
11.4.2. Viral Infection
11.5. Oncology
11.5.1. Hematological Malignancy
11.5.2. Solid Tumor
12. Americas Pharmaceutical Customized R&D & Production Services Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pharmaceutical Customized R&D & Production Services Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lonza Group AG
15.3.2. Catalent, Inc.
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. WuXi AppTec Co., Ltd.
15.3.5. Samsung Biologics Co., Ltd.
15.3.6. Boehringer Ingelheim International GmbH
15.3.7. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
15.3.8. Recipharm AB
15.3.9. AGC Biologics Inc.
15.3.10. Rentschler Biopharma SE
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET: RESEARCHAI
FIGURE 24. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET: RESEARCHCONTACTS
FIGURE 26. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY DMPK, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY DMPK, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY API MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY FILL FINISH MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY FILL FINISH MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY NONVIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY NONVIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SYNTHETIC PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SYNTHETIC PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ESTABLISHED BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ESTABLISHED BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STARTUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STARTUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MID SIZED PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MID SIZED PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SOLID TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 197. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2018-2024 (USD MILLION)
TABLE 198. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2025-2030 (USD MILLION)
TABLE 199. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 200. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 201. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 202. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 203. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 204. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 205. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2018-2024 (USD MILLION)
TABLE 206. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2025-2030 (USD MILLION)
TABLE 207. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 210. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 211. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 212. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 213. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2018-2024 (USD MILLION)
TABLE 214. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CUSTOMER CATEGORY, 2025-2030 (USD MILLION)
TABLE 215. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 216. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 217. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 218. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 219. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 220. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 221. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 222. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 223. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 224. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 225. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 226. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 227. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 228. CANADA PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY SERVICE CATEGORY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY INTEGRATED DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY MOLECULE CATEGORY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES MARKET SIZE, BY PEPTIDES AND OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PHARMACEUTICAL CUSTOMIZED R&D & PRODUCTION SERVICES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pharmaceutical Customized R&D & Production Services market report include:
  • Lonza Group AG
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Samsung Biologics Co., Ltd.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Recipharm AB
  • AGC Biologics Inc.
  • Rentschler Biopharma SE

Related Topics

Related Reports

Pharmaceuticals - Enterprise ICT - Product Image

Pharmaceuticals - Enterprise ICT

  • Report
  • 54 Pages
  • Global
From
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028 - Product Image

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 286 Pages
  • North America
From
Asia-Pacific Pharmaceutical Industry Outlook 2023 - Product Image

Asia-Pacific Pharmaceutical Industry Outlook 2023

  • Report
  • 77 Pages
  • Asia Pacific
From
EGFR-TKI Market - Global Forecast 2025-2030 - Product Image

EGFR-TKI Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Active Pharmaceutical Ingredients Market Size, Share, Trends and Forecast by Drug Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, and Region, 2025-2033 - Product Image

Active Pharmaceutical Ingredients Market Size, Share, Trends and Forecast by Drug Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, and Region, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.